Table 2 False-positive cases characteristics, pathology of index tumors, and additional primary malignancies, diagnostic procedures, and outcomes
| Â | Age | Sex | 1 site | Path | Diagnosis | Outcome | Interval | 2 | Path | Diagnosis | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|
22 | 55 | M | Liver | HCC | FNAC | RFA | 0 | GB | Cholecystitis | FU/US | Medical TTT |
23 | 35 | F | Breast | Invasive ductal carcinoma | FNAC | Lumpectomy/chemotherapy | 0 | Lung | Post pneumonic nodule | Biopsy | FU |
24 | 32 | F | Breast | Invasive ductal carcinoma | FNAC | Mastectomy/chemo-radio | 6M | Colon | Colitis | Endoscopy | Medical TTT |
25 | 28 | F | Colon | Infiltrating adenocarcinoma | Endoscopy | Colostomy/chemotherapy | 0 | Breast | Fibroadenoma | Excision | lumpectomy |
26 | 32 | F | Breast | Invasive ductal carcinoma | FNAC | Lumpectomy/chemo-radio | 0 | Thyroid | Thyroiditis | FNAC | Medical TTT |
27 | 60 | M | Colon | Adenocarcinoma | Endoscopy | Colostomy/ chemotherapy | 9M | adrenal | Metachronous Metastasis | FNAC | chemotherapy |
28 | 60 | F | Lymphoma | NHL(LBC) | LN. excision | Chemotherapy | 0 | Parotid | Pleo-morphic adenoma | FNAC | Excision |
29 | 45 | M | Lymphoma | NHL(LBC) | Tissue biopsy | Chemotherapy | 0 | Colon | Colitis | Endoscopy | Medical TTT |
30 | 54 | F | Lymphoma | NHL(LBC) | Tissue biopsy | Chemotherapy | 1 year | Breast | Fibroadenoma | FNAC | Excision |